Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 8-61 is a protein coding gene encoding the variable region of the lambda light chain segment of immunoglobulins (“antibodies”). This segment is involved in the antigen-binding site, pairing with the variable domain of the heavy chain in the immunoglobulin molecule. During B lymphocyte development, V-(D)-J recombination and subsequent somatic hypermutation produce diversity, enabling this region to bind a vast array of antigens. The protein is part of the immunoglobulin complex and contributes to the recognition phase of humoral immunity, initiating antigen-specific immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 8-61 (IGLV8-61).